The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction
Open accessAbstract
Although tumor-specific T cells recognize cancer cells, they are often rendered dysfunctional due to an immunosuppressive microenvironment. Here we showed that T cells demonstrated persistent loss of mitochondrial function and mass when infiltrating murine and human tumors, an effect specific to the tumor microenvironment and not merely caused by activation. Tumor-infiltrating T cells showed a progressive loss of PPAR-gamma coactivator 1α (PGC1α), which programs mitochondrial biogenesis, induced by chronic Akt signaling in tumor-specific T cells. Reprogramming tumor-specific T cells through enforced expression of PGC1α resulted in superior intratumoral metabolic and effector function. Our data support a model in which signals in the tumor microenvironment repress T cell oxidative metabolism, resulting in effector cells with metabolic needs that cannot be met. Our studies also suggest that modulation or reprogramming of the altered metabolism of tumor-infiltrating T cells might represent a potential strategy to reinvigorate dysfunctional T cells for cancer treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Exhausted T cells and tumor-infiltrating NK cells also exhibit dysregulated mitochondrial biogenesis, a mechanism that has created interest in using strategies to improve mitochondrial biogenesis to promote tumor immunity (Scharping et al., 2016; Zheng et al., 2019).”
From Hallmarks of response, resistance, and toxicity to immune checkpoint blockade (2021) · cites this paper as Scharping et al., 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular and cellular insights into T cell exhaustion
Wherry, E. J., & Kurachi, M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3862 · Cited by 4,652
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chang, C.-H., Qiu, J., O’Sullivan, D., Buck, M. D., Noguchi, T., Curtis, J. D., Chen, Q., Gindin, M., Gubin, M. M., van der Windt, G. J. W., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.016 · Cited by 3,331
Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice
Kim, J. M., Rasmussen, J. P., & Rudensky, A. Y. (2006) · Nature Immunology · doi:10.1038/ni1428 · Cited by 1,827
Mitochondria as sensors and regulators of calcium signalling
Rizzuto, R., De Stefani, D., Raffaello, A., & Mammucari, C. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3412 · Cited by 1,781
Woo, S.-R., Turnis, M. E., Goldberg, M. V., Bankoti, J., Selby, M., Nirschl, C. J., Bettini, M. L., Gravano, D. M., Vogel, P., Liu, C. L., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1620 · Cited by 1,647
Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development
van der Windt, G. J. W., Everts, B., Chang, C.-H., Curtis, J. D., Freitas, T. C., Amiel, E., Pearce, E. J., & Pearce, E. L. (2012) · Immunity · doi:10.1016/j.immuni.2011.12.007 · Cited by 1,540
Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses
Ho, P.-C., Bihuniak, J. D., Macintyre, A. N., Staron, M., Liu, X., Amezquita, R., Tsui, Y.-C., Cui, G., Micevic, G., Perales, J. C., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.012 · Cited by 1,462
PGC-1 coactivators: inducible regulators of energy metabolism in health and disease
Finck, B. N. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27794 · Cited by 1,461
Fueling Immunity: Insights into Metabolism and Lymphocyte Function
Pearce, E. L., Poffenberger, M. C., Chang, C.-H., & Jones, R. G. (2013) · Science · doi:10.1126/science.1242454 · Cited by 1,363
Combination cancer immunotherapy and new immunomodulatory targets
Mahoney, K. M., Rennert, P. D., & Freeman, G. J. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4591 · Cited by 1,294
Flagged first, then by citations
Research works printed but not linked: 1
- Scarpulla, 2011, Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochimica et Biophysica Acta (BBA) -, Molecular Cell Research, 1813, 1269
Cited by
Sorted by citations
Items 501–600 of 847
IL3-Driven T Cell–Basophil Crosstalk Enhances Antitumor Immunity
Wei, J. N., Mayberry, C. L., Lv, X., Hu, F., Sears, J. D., Khan, T., Logan, N. A., Sears, J. D., Chaussabel, D., & Chang, C. (2024) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-23-0851 · Cited by 11
Moraly, J., Kondo, T., Benzaoui, M., DuSold, J., Talluri, S., Pouzolles, M., Chien, C. D., Dardalhon, V., & Taylor, N. N. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13691 · Cited by 12
Gubser, P. M., Wijesinghe, S. K. M., Heyden, L., Gabriel, S. S., Souza, D. P. D., Hess, C., McConville, M. M., Utzschneider, D. T., & Kallies, A. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114632 · Cited by 14
Carbon-Based Nanoarchitectonics in Advancing Cardiac Tissue Bioprinting: A Review
Dixit, M., Shrestha, L. K., Ariga, K., & Pati, F. (2024) · ACS Applied Nano Materials · doi:10.1021/acsanm.4c04441 · Cited by 11
Lipids guide T cell antitumor immunity by shaping their metabolic and functional fitness
Rumiano, L., & Manzo, T. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.11.014 · Cited by 12
Sung, J., & Kim, E. T. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07244-1 · Cited by 11
Khurana, P., Burudpakdee, C., Grupp, S. A., Beier, U. H., Barrett, D. M., & Bassiri, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.700374 · Cited by 11
Song, D., Zhou, Z., Zhang, D., Wu, J., Hao, Q., Zhao, L., Ren, H., & Zhang, B. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.850200 · Cited by 11
Immuno-onco-metabolism and Therapeutic Resistance
Mir, M. A., Aisha, S., Nisar, S., Qayoom, H., & Mehraj, U. (2022) · Springer eBooks · doi:10.1007/978-981-16-6226-3_3 · Cited by 11
Defining and targeting patterns of T cell dysfunction in inborn errors of immunity
Campos, J. S., & Henrickson, S. E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.932715 · Cited by 12
Repas, J., Peternel, L., Sourij, H., & Pavlin, M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1216193 · Cited by 12
Suppressing immunotherapy by organ-specific tumor microenvironments: what is in the brain?
Zhang, C., & Yu, D. (2019) · Cell & Bioscience · doi:10.1186/s13578-019-0349-0 · Cited by 11
Exploiting immunometabolism and T cell function for solid organ transplantation
Allocco, J., & Alegre, M. (2020) · Cellular Immunology · doi:10.1016/j.cellimm.2020.104068 · Cited by 11
Mitochondrial lipid metabolism in tumor immunosurveillance and evasion
Plata-Gómez, A. B., Chen, W., Ho, P., & Ling, G. S. (2025) · Trends in Immunology · doi:10.1016/j.it.2025.08.005 · Cited by 12
Cancer suppresses mitochondrial chaperone activity in macrophages to drive immune evasion
Zhao, H., Park, J., Wang, Y., Chou, Y.-J., Li, L., Raines, L. N., Hsu, M., Lin, C.-C., Cao, W., Ouyang, Y., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02324-2 · Cited by 11
Scharping, N. E., Ge, X., Matias, M. I., Jiang, F., Cafferata, A., Heeg, M., Monell, A., Galletti, G., Cheung, K. P., Rock, A. E., et al. (2025) · Cell · doi:10.1016/j.cell.2026.02.019 · Cited by 12
Self-citationZhu, T., Teng, X., Jiao, Q., Ren, Y., Wang, Y., & Feng, M. (2026) · Clinical and Translational Medicine · doi:10.1002/ctm2.70609 · Cited by 12
A novel computational tool for tracking cancer energy hijacking from immune cells
Zhang, H., & Li, B. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1533 · Cited by 9
Mitochondrial bioenergetics of breast cancer
Singh, T., Sharma, K., Jena, L., Kaur, P., Singh, S., & Munshi, A. (2024) · Mitochondrion · doi:10.1016/j.mito.2024.101951 · Cited by 11
Zhou, W., Qu, M., Yue, Y., Zhong, Z., Nan, K., Sun, X., Wu, Q., Zhang, J., Chen, W., & Miao, C. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01848-8 · Cited by 11
Resident Memory T Cells in the Tumor Microenvironment
Williams, J. B., & Kupper, T. S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-49270-0_3 · Cited by 11
Dotsu, Y., Muraoka, D., Ogo, N., Sonoda, Y., Yasui, K., Yamaguchi, H., Yagita∥, H., Mukae, H., Asai, A., & Ikeda, H. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003958 · Cited by 11
Venzel, R., Campos, M. C. P., de Oliveira, L. P., Lins, R. V. D., Siena, Á. D. D., Mesquita, K. T., dos Santos, T. P. M., Nohata, N., Arruda, L. C. M., Sales‐Campos, H., et al. (2023) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2023.103988 · Cited by 10
Tian, H., Zhang, B., Li, L., Wang, G., Li, H., & Zheng, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01692 · Cited by 10
Impact of concomitant fibrates on immunotherapy outcomes for advanced non‐small cell lung cancer
Stokes, W. A., Behera, M., Jiang, R., Gutman, D. A., Huang, Z., Burns, A., Sebastian, N., Sukhatme, V. V., Lowe, M., Ramalingam, S. S., et al. (2022) · Cancer Medicine · doi:10.1002/cam4.4847 · Cited by 10
Ebi3 Binding to IFN-γ and IL-10 Limits Their Function
Scott, E. N., Ye, C., Yano, H., Lipatova, Z., Brunazzi, E. A., Vignali, K. M., Workman, C. J., & Vignali, D. A. A. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2400236 · Cited by 9
Mechanism of the Warburg effect and its role in breast cancer immunotherapy
Saheed, E. S., Aromolaran, R. F., Atoyebi, A. D., Adeleke, F. C., Otuyalo, A. I., & Edozie, P. K. (2024) · Discover Medicine · doi:10.1007/s44337-024-00131-6 · Cited by 10
Metabolic heterogeneity in tumor cells impacts immunology in lung squamous cell carcinoma
Wang, Q., Sun, N., Zhang, C., Kunzke, T., Zens, P., Feuchtinger, A., Berezowska, S., & Walch, A. K. (2025) · OncoImmunology · doi:10.1080/2162402x.2025.2457797 · Cited by 9
Jin, J., Zhang, R., Li, J., Gao, F., Liao, Z., Yu, Y., Wang, Y., Bucci, D. M., Xiao, M., Ma, R., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2424061122 · Cited by 9
Bhutani, B., Sharma, V., Ganguly, N. K., & Rana, R. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.117987 · Cited by 9
Innovative approaches to CAR-T cell therapy: the role of lipid metabolism pathways
Guo, M., Zhang, Y., Yuan, X. H., & Wang, X. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06718-6 · Cited by 9
Xu, W.-X., Ye, Y., Chen, J., Guo, X., Li, C., Luo, J., Lu, L., & Chen, X. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1606195 · Cited by 9
Ciancaglini, C., Santopolo, S., Martini, S., Scordamaglia, F., Pietropaolo, G., Laffranchi, M., Sciumè, G., Ferlazzo, G., Vacca, P., Moretta, L., et al. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01347-x · Cited by 9
Yang, J., Li, M., Wei, Z., Qian, J., Chu, M., Qiang, Z., & Ren, J. (2025) · ACS Nano · doi:10.1021/acsnano.5c08486 · Cited by 10
Mitochondria-targeted strategies in tumor immunity
Cheng, X., Wang, Y., Johnson, B., & You, M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1646138 · Cited by 10
“Dissecting the role of T cell exhaustion in cancer progression: a multifaceted approach“
Li, X., & Song, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1646292 · Cited by 12
Scaglione, M., Knight, M., Trihemasava, K., Rome, K., Archambault, A., Oh, J., Tanaka, E., Hall, E., Le, T. N. V., Lines, C. L., et al. (2026) · Immunity · doi:10.1016/j.immuni.2026.04.004 · Cited by 10
The potential of aryl hydrocarbon receptor as receptors for metabolic changes in tumors
Wang, Z., Zhang, Y., Liao, Z., Huang, M., & Shui, X. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1328606 · Cited by 9
Lipid Metabolism in Tumor-Infiltrating T Cells
He, S., Cai, T., Yuan, J., Zheng, X., & Yang, W. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-33-6785-2_10 · Cited by 9
Zhang, Y., Li, W., Ma, K., Zhai, J., Jin, Y., Zhang, L., & Chen, C. (2022) · Immunology Letters · doi:10.1016/j.imlet.2022.04.003 · Cited by 9
Autophagic flux restoration enhances the antitumor efficacy of tumor infiltrating lymphocytes
Zhang, C., Sun, Y., Li, S., Shen, L., Teng, X., Xiao, Y., Wu, N., & Lu, Z. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-004868 · Cited by 9
Patwardhan, R. S., Gohil, D., Singh, B., Kumar, B. K., Purohit, V., Thoh, M., Checker, R., Gardi, N., Gota, V., Kutala, V. K., et al. (2024) · Phytotherapy Research · doi:10.1002/ptr.8126 · Cited by 8
Pandey, S., Anang, V., & Schumacher, M. M. (2024) · International review of cytology · doi:10.1016/bs.ircmb.2024.07.003 · Cited by 8
Metabolic Regulation of T Cell Exhaustion
Wu, H., Prados, M. C., & Vaeth, M. (2025) · Immune discovery. · doi:10.70322/immune.2025.10005 · Cited by 10
Targeting Metabolic Reprogramming in Bladder Cancer Immunotherapy: A Precision Medicine Approach
Liu, F., Li, K., & Zhu, Q. (2025) · Biomedicines · doi:10.3390/biomedicines13051145 · Cited by 8
Ton, N. Q. C., & Park, P. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.108015 · Cited by 10
Striking the right balance with type I interferon signalling in cancer
Chadwick, T. B., So, J., Hertzog, P. J., Haynes, N. M., & Parker, B. S. (2026) · Nature reviews. Cancer · doi:10.1038/s41568-026-00915-1 · Cited by 14
Feeling Worn Out? PGC1α to the Rescue for Dysfunctional Mitochondria in T Cell Exhaustion
Balmer, M. L., & Hess, C. (2016) · Immunity · doi:10.1016/j.immuni.2016.07.024 · Cited by 8
RNA Flow Cytometry for the Study of T Cell Metabolism
Rossi, A., Pacella, I., & Piconese, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083906 · Cited by 10
Bousquet, P. A., Meltzer, S., Fuglestad, A. J., Lüders, T., Esbensen, Y., Juul, H. V., Johansen, C., Lyckander, L. G., Bjørnetrø, T., Inderberg, E. M., et al. (2021) · Clinical & Translational Oncology · doi:10.1007/s12094-021-02756-w · Cited by 8
Autophagy-inducing nutritional interventions in experimental and clinical oncology
Hofer, S. J., Kroemer, G., & Kepp, O. (2022) · International review of cytology · doi:10.1016/bs.ircmb.2022.08.003 · Cited by 8
CD8+ T cell metabolic changes in breast cancer
Castoldi, Â., Lee, J., Carvalho, D. D. S., & Souto, F. O. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166565 · Cited by 9
Hu, Y. W., Mu, H., & Deng, Z. (2022) · Tissue and Cell · doi:10.1016/j.tice.2022.101964 · Cited by 8
Immune Cell Metabolism and Immuno-Oncology
Patel, C. H., & Powell, J. D. (2023) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-061421-042605 · Cited by 9
Multiplexed Single-cell Metabolic Profiles Organize the Spectrum of Cytotoxic Human T CellsPreprint
Hartmann, F. J., Mrdjen, D., McCaffrey, E., Glass, D. R., Greenwald, N. F., Bharadwaj, A., Khair, Z., Baranski, A., Baskar, R., Angelo, M., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.17.909796 · Cited by 8
Flati, I., Nolfi, M. D. V., Dall’Aglio, F., Vecchiotti, D., Verzella, D., Alesse, E., Capece, D., & Zazzeroni, F. (2023) · Genes · doi:10.3390/genes14101953 · Cited by 7
Sasmal, P., Prabitha, P., Kumar, B. R. P., Swetha, B. R., Babasahib, S. K., & Raghavendra, N. M. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.108036 · Cited by 8
Targeting organelle function in T cells for cancer immunotherapy
Baldwin, J., Heuser-Loy, C., & Gattinoni, L. (2025) · Nature reviews. Immunology · doi:10.1038/s41577-025-01223-9 · Cited by 8
The Rise of Fine-Tuned CAR-Based Therapies Against Acute Myeloid Leukemia
Segura‐Tudela, A., Geller, R., Paiva, B., Sánchez, S. C. T., Romero, E. G., Madrid, P. L., Chorão, P., de la Rubia, J., Montesinos, P., & Guerreiro, M. (2025) · Cancers · doi:10.3390/cancers17243892 · Cited by 7
Muth, A., Holzem, A. M. E., Neumann, A.-S., Bücklein, V., Subklewe, M. S., & Philipp, N. (2026) · Med · doi:10.1016/j.medj.2026.101031 · Cited by 9
Zhu, Q., Wang, J., Yu, H., Hu, Q., Bateman, N. W., Long, M. D., Rosario, S. R., SCHULTZ, E. A., Dalgard, C. L., Wilkerson, M. D., et al. (2022) · Cancers · doi:10.3390/cancers14102350 · Cited by 7
Apoptotic Regulatory T Cells Retain Suppressive Function through Adenosine
Beier, U. H. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.12.013 · Cited by 7
Wang, G., Wang, H., Cheng, S., Zhang, X., Feng, W., Zhang, P., & Wang, J. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.993594 · Cited by 7
Regulation of immune cell metabolism by cancer cell oncogenic mutations
Madi, A., & Cui, G. (2020) · International Journal of Cancer · doi:10.1002/ijc.32888 · Cited by 7
Gene expression signatures identify biologically and clinically distinct tuberculosis endotypesPreprint
DiNardo, A. R., Gandhi, T., Heyckendorf, J., Grimm, S. L., Rajapakshe, K., Nishiguchi, T., Reimann, M., Kahari, J., Dlamini, Q., Lange, C. G., et al. (2020) · medRxiv · doi:10.1101/2020.05.13.20100776 · Cited by 7
The Glucose Transporter 5 Enhances CAR-T Cell Metabolic Function and Anti-tumour DurabilityPreprint
O’Connor, R. S., Valentić, B., Kelly, A. R., Shestov, A. A., Gan, Z., Shen, F., Chatoff, A. G., Jaccard, A., Crispim, C. V. D. S., Scholler, J., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4342820/v1 · Cited by 7
The Emerging Role of CD8+ T Cells in Shaping Treatment Outcomes of Patients with MDS and AML
Tasis, A., Spyropoulos, T., & Mitroulis, I. (2025) · Cancers · doi:10.3390/cancers17050749 · Cited by 6
Mitochondria in cancer: a comprehensive review, bibliometric analysis, and future perspectives
Wakil, A. E., Devos, P., Abdelmegeed, H., & Kamel, A. (2025) · Discover Oncology · doi:10.1007/s12672-025-02139-5 · Cited by 7
Li, R., Li, S., Li, H., Liu, B., Wang, Z., Lei, H., Li, Y., Jia, L., Li, J., Lu, H., et al. (2025) · Mediators of Inflammation · doi:10.1155/mi/6217272 · Cited by 6
Rukonge, P. A., Kawuribi, V., Sheng, Y., Wei, Q., Kun, Y., Niyodukunda, P., Wang, T., Lu, Z., Miao, Y., Xu, K., et al. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.105094 · Cited by 6
Si, L., Wei, D., Pan, J., Baleeiro, R. B., Chard, L. S., & Wang, Y. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218240 · Cited by 7
Dutta, G., Mishra, P., Mishra, S. P., & Badhai, J. (2026) · Onco · doi:10.3390/onco6030031 · Cited by 7
Targeting T cell metabolism for immunotherapy
Gao, J., Liu, Y., Wei, J., Jiang, L., Mao, J., Chang, C.-H., & Wu, D. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.5mr0921-011r · Cited by 6
Yang, K., Ma, Y., Chen, W., Liu, L., Yang, Z., He, C., Zheng, N., Liu, X., Cheng, X., Song, J., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-59154-9 · Cited by 6
Chen, B., Lü, M., Chen, Q., Zou, E., Bo, Z., Li, J., Zhao, R., Zhao, J., Yu, Z., Chen, G., et al. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1430885 · Cited by 6
Meyo, M. T., Boudou, P., Arrondeau, J., Chen, J., Hirsch, L., Neveux, N., Fabre, E., Guidet, C., Damotte, D., Wislez, M., et al. (2024) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2024.09.002 · Cited by 6
Targeting fatty acid metabolism for cancer therapy
Zhang, L., Yao, Y., & Liu, S. (2024) · Fundamental Research · doi:10.1016/j.fmre.2024.09.011 · Cited by 8
Xiao, Y., Pang, N., Ma, S., Gao, M., & Yang, L. (2024) · Nutrients · doi:10.3390/nu16213577 · Cited by 6
de Assis, E. B. T., Ferreira, M. Y., de Oliveira, J. S., Mitre, L. P., Corrêa, E. M., Coelho, L. L. S., Moreno, D. A., & Polverini, A. D. (2025) · World Neurosurgery · doi:10.1016/j.wneu.2025.123842 · Cited by 6
Role of Metabolism in Adoptive T Cell Therapy: Strategies and Challenges
Tan, G. H., & Wong, C. C. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0037 · Cited by 6
Defective mitochondria disrupt CD8+ T cells
Leavy, O. (2016) · Nature reviews. Immunology · doi:10.1038/nri.2016.98 · Cited by 6
Lee, H. W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126290 · Cited by 6
Sanchez, J., Jackson, I., Flaherty, K. R., Muliaditan, T., & Schurich, A. (2020) · Metabolites · doi:10.3390/metabo10110461 · Cited by 5
Targeting mitochondrial damage: shining a new light on immunotherapy
Zeng, W., Wang, M., Zhang, Y., Zhou, T., & Zong, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1432633 · Cited by 5
Guo, Z., Yao, Z., Chen, X., Wu, D., Ouyang, Y., Shen, Y., Wang, Y., Zhang, H., Lu, Y., & Lv, W. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01906-6 · Cited by 5
Kazane, K. R., Labarta-Bajo, L., Zangwill, D., Liimatta, K., Vargas, F., Weldon, K. C., Dorrestein, P., & Zúñiga, E. I. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2419820122 · Cited by 9
Cruz, C., & Barba, I. (2026) · Metabolites · doi:10.3390/metabo16010075 · Cited by 6
Metabolic traits of T cells and the implications in autoimmune diseases
Zhou, Y., Zhou, Y., Zhu, Q., Guo, W., & Li, C. (2026) · Autoimmunity Reviews · doi:10.1016/j.autrev.2026.103989 · Cited by 6
Wang, Z., Wang, L. E., Ji, M., 娄杰, Yuan, Y., Cui, Y., Xiang, G., & Zhou, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1734880 · Cited by 5
Combinatorial in situ cancer vaccines: unlocking broad and enhanced antitumor responses
Chen, W., Baig, J., Choi, H., & Son, S. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02821-2 · Cited by 5
Current hotspots and trends in cancer metabolic reprogramming: a scientometric analysis
Yang, S., Lin, M., Hao, S., Ye, H., & Zhang, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1497461 · Cited by 5
Advances in cancer immunotherapy: The role of super NK and super CAR-T cells
Almohaimeed, H. M., Chowdhury, A., Sarkar, S., Almars, . I., Tounsi, W. A., Singh, A., Krithiga, T., Ray, S., & Uti, D. E. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115074 · Cited by 7
Ferroptosis-Related Genes with Regard to CTLA-4 and Immune Infiltration in Hepatocellular Carcinoma
Xu, J., Wu, X., & Wang, X. (2022) · Biochemical Genetics · doi:10.1007/s10528-022-10279-4 · Cited by 5
Interplay Between Metabolic Sensors and Immune Cell Signaling
Chauhan, P. S., Sarkar, A., & Saha, B. (2018) · Experientia supplementum · doi:10.1007/978-3-319-74932-7_3 · Cited by 5
DURHAN, A., ŞENLİKÇİ, A., KOŞMAZ, K., ERGÜDER, E., Mercan, Ü., & SÜLEYMAN, M. (2021) · Journal of College of Physicians And Surgeons Pakistan · doi:10.29271/jcpsp.2021.03.282 · Cited by 5
Saleki, K., & Rezaei, N. (2022) · Springer eBooks · doi:10.1007/978-3-030-80962-1_9-1 · Cited by 5
Potentiating the anti-tumor response of tumor infiltrated T cells by NAD + supplementationPreprint
Wang, Y., Wang, F., Wang, L., Qiu, S., Yao, Y., Xiong, X., Chen, X., Ji, Q., Cao, J., Li, D., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.21.001123 · Cited by 5
Wang, H., Chen, L., Mao, Z.-C., Liu, S., Huang, R.-Z., He, R.-J., Zhang, Y., & Wei, J.-H. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00384 · Cited by 5
Xie, L., Zhou, Y., Hu, Z., Zhang, W., & Zhang, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1679464 · Cited by 4
Galloway, A., Knop, K., Gómez-Moreira, C., Xavier, V., Thomson, S., Yoshikawa, H., Suska, O., Lukoszek, R., Kaskar, A., Lamond, A. I., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116412 · Cited by 4
Metadata
- Authors
- Scharping, N. E., Menk, A. V., Moreci, R. S., Whetstone, R. D., Dadey, R. E., Watkins, S. C., Ferris, R. L., & Delgoffe, G. M.
- Affiliations
- University of Pittsburgh (US)
- UPMC Hillman Cancer Center (US)
- Corresponding author
- Delgoffe, Greg M.
- ORCID
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2016-08
- Volume
- 45
- Issue
- 2
- Pages
- 374-388
- ISSN
- 1074-7613 (ISSN-L)
- PMC
- PMC5207350
- OpenAlex
- W4294138012
- Cited by
- 848
- References
- 44
- Citations by year
- 2026: 136 · 2025: 111 · 2024: 113 · 2023: 97 · 2022: 109 · 2021: 90 · 2020: 76 · 2019: 42 · 2018: 33 · 2017: 34 · 2016: 7
- FWCI
- 20.82
- Type
- journal article
- Language
- en
- Update notices
- erratum (2016-09-20)
- Open access
- bronze
- doi.org
- Licence
- Locations
- Immunity (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (1s10od016236-01)
- National Cancer Institute (P50CA121973, P50CA097190, P30CA047904)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- tumor microenvironment, PGC-1α, Akt signaling, T cell metabolism, oxidative metabolism, tumor-infiltrating T cells, T cell dysfunction, immunosuppression, metabolic reprogramming, cancer immunotherapy
- MeSH terms
- Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Animals, Colonic Neoplasms, Humans, Mice, Inbred C57BL, Mice, Transgenic, Mitochondria, Neoplasms, Experimental, T-Lymphocytes, Signal Transduction, Lymphocytes, Tumor-Infiltrating, Oxidative Stress, Cell Line, Tumor, PPAR gamma, Oncogene Protein v-akt, Mice, Tumor Microenvironment, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
